Loading...
 
Back to the list
Mediterr J Rheumatol 2020;31(Supp 1):163-71
Article Links
Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
Dimitrios Vassilopoulos1, Spiros Aslanidis2, Dimitrios Boumpas3, George Kitas4, Spyridon N. Nikas5, Dimos Patrikos6, Petros P. Sfikakis7, Prodromos Sidiropoulos8
Authors Information
1. Joint Rheumatology Program, 2nd Department of Medicine and Laboratory, National and Kapodistrian University of Athens, School of Medicine, Hippokration General Hospital, Athens, Greece
2. Private Practice, Thessaloniki, Greece
3. Joint Rheumatology Program, 4th Department of Medicine, National and Kapodistrian University of Athens, School of Medicine, Attikon University General Hospital, Athens, Greece
4. Hygeia Hospital, Athens, Greece
5. Private Practice, Ioannina, Greece
6. Metropolitan Hospital, Piraeus, Greece
7. Joint Rheumatology Program, 1st Dept of Propaedeutic & Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laiko General Hospital, Athens, Greece
8. Clinical Immunology and Allergy Department, Medical School, University of Crete, Heraklion, Greece
Keywords: Rheumatoid arthritis, guidelines, therapy, biologics, disease modifying anti-rheumatic drugs
References
  1. Singh JA, Saag KG, Bridges SL Jr., Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol 2016;68:1-26.
  2. Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960-77.
  3. Kay J, Schoels MM, Dorner T, Emery P, Kvien TK, Smolen JS, et al. Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. Ann Rheum Dis 2018 Feb;77(2):165-74.
  4. Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Álvaro-Gracia JM, et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 2017;76:948-59.
  5. Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3-15.
  6. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.